Aemetis (AMTX) Q3 2024 earnings summary

Executive summary

• Q3 2024 revenue rose to $81.4M, up 18.6–19% year-over-year, driven by growth in ethanol, RNG, and India biodiesel segments.

• Net loss was $17.9M, compared to net income of $30.7M in Q3 2023, reflecting the absence of a one-time tax credit sale and higher interest expense.

• Gross profit increased to $3.9M from $492K year-over-year; operating loss narrowed to $3.9M from $8.5M.

• The company is expanding renewable natural gas operations and developing new SAF/renewable diesel and carbon capture projects.

• Regulatory tailwinds from California's updated LCFS and anticipated federal 45Z tax credits are expected to boost future revenues.

Financial highlights

• Q3 2024 revenue: $81.4M (up from $68.7M in Q3 2023); nine-month revenue: $220.6M (up from $116.0M year-over-year).

• Gross profit: $3.9M (vs. $492K in Q3 2023); nine-month gross profit: $1.5M (vs. $1.2M year-over-year).

• Operating loss: $3.9M (improved from $8.5M loss in Q3 2023); nine-month operating loss: $26.9M (vs. $28.4M 2023).

• Net loss: $17.9M (vs. net income of $30.7M in Q3 2023, which included a large tax credit sale); nine-month net loss: $71.3M (vs. $21.0M loss year-over-year).

• Cash at quarter end: $296K (down from $2.7M at 2023 year-end).

Outlook and guidance

• LCFS credit revenues and federal 45Z tax credits expected to drive significant revenue growth in 2025.

• RNG production run rate targeted at 550,000 MMBtu by end of 2024 and 1M MMBtu by end of 2025.

• $11.5M in tax credit sales expected in Q4 2024, with another $10M in Q1 2025.

• India biodiesel contract renewal and IPO targeted for 2025, pending market conditions.

• Management is pursuing debt refinancing, equity sales, and project-specific funding to address liquidity needs.